Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05792423 · ClinicalTrials.gov registry record · NA
Conditionally Increased Output (CIO) Enhanced Ultrasound System
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05792423: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05792423 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05792423, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study aims to assess possible bioeffects that may be caused by the use of shear wave elastography (SWE) with conditionally increased acoustic output pressure (CIO). Bioeffects will be monitored by of a series of liver function tests (LFTs) with results graded according to the NCI scale for drug hepatoxicity. LFTs will be collected prior to SWE imaging using CIO, as well up to 7 days post-imaging. Secondarily, this study aims to understand the degree to which SWE imaging results have improved with the use of COI.
Interventions
- DEVICE GE ultrasound system with increased acoustic output settings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-06-30 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05792423
The ClinicalTrials.gov registry entry for NCT05792423 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GE ultrasound system with increased acoustic output settings is the first listed.
NCT05792423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05792423 about?
NCT05792423 is a clinical study titled "Conditionally Increased Output (CIO) Enhanced Ultrasound System". This study aims to assess possible bioeffects that may be caused by the use of shear wave elastography (SWE) with conditionally increased acoustic output pressure (CIO). Bioeffects will be monitored by of a series of liver function tests (LFTs) with results graded according to the NCI scale for drug...
What is the current status of trial NCT05792423?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-06-30. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05792423?
The interventions under investigation include: GE ultrasound system with increased acoustic output settings (DEVICE).
Who is sponsoring clinical trial NCT05792423?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.